3136 results for «2757»
3136 results
VitaFlow - The electrically enable self-expanding TAVI valve
21 Nov 2023 – From PCR London Valves 2023
This session provides insights into the unique design and advantages of VitaFlow Liberty for TAVI. It covers techniques to minimize microdislodgement during the procedure, identifies situations and patient types most suitable for VitaFlow Liberty, and reviews early clinical results associated with this technology.
Facing the challenges of resource shortages - An outlook into the future of TAVI?
21 Nov 2023 – From PCR London Valves 2023
Join this session to discover strategies for optimizing care quality and patient safety, especially in resource-constrained environments. Gain insights into variations in TAVI patient treatment across European countries, understanding the associated consequences. Engage in discussions exploring potential solutions to ensure long-term, high-quality patient care despite challenges...
An intrepid solution for transfemoral treatment of mitral regurgitation
21 Nov 2023 – From PCR London Valves 2023
In this session, get insights into the APOLLO EU trial and its current progress, obtain a comprehensive understanding of the latest data from the Early Feasibility TF trial, and discern which patients stand to benefit the most from this treatment.
Best contemporary clinical practice for TAVI
21 Nov 2023 – From PCR London Valves 2023
Watch this session if you wish to explore emerging trends for transcatheter aortic valve implantation in younger patients, the specific considerations for TAVI in individuals with an extended life expectancy, and examine how valve design and implantation techniques can impact long-term outcomes.
Finishing strong - Latest best practices and technologies for large hole arterial and venous closure
21 Nov 2023 – From PCR London Valves 2023
Consult this session to grasp the current landscape of techniques for closing large holes in both arterial and venous contexts. Acquire valuable tips and tricks aimed at minimizing vascular complications, and learn about the innovative patch-based closure approach for a comprehensive understanding.
Addressing remaining issues after TAVI: what to expect from the new generation?
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to discuss the challenges of TAVI for lower-risk patients, and to capture the features of new TAVI devices.
Controversies in atrioventricular valves - The Heart Team ring, Vol II
19 Nov 2023 – From PCR London Valves 2023
This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Participate in discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
My patient with complex angiogram
15 May 2023 – From EAPCI-PCR Fellows course 2023
Consult these slides to learn how to efficiently perform intracoronary imaging and physiological assessment in your cath lab, to learn how to interpret IVUS and OCT images and to implement intracoronary physiology and imaging tools into the decision making in a MVD patient.
My patient with STEMI
15 May 2023 – From EAPCI-PCR Fellows course 2023
Consult these slides to understand the challenges of primary PCI, to discuss contemporary approaches to multivessel PCI in STEMI and to learn how to prevent and manage complications during primary PCI.
The catheter-based treatment revolution is just getting started
19 Nov 2023 – From PCR London Valves 2023
Consult this session to stay updated on the latest advancements in transcatheter aortic valve implantations and interventions for tricuspid regurgitation. Gain insights into how recent evidence and innovations are reshaping the treatment landscape for valvular heart disease.
TAVI and beyond: tackling coronary challenges
19 Nov 2023 – From PCR London Valves 2023
Consult this session to gain a comprehensive understanding of the crucial role of coronary access post-TAVI, and the impact of TAV design and implantation technique on coronary access. Gain some insights into the intricacies of coronary accessibility from extensive bench test work and the impact of TAV design in...
A problem and a solution: aortic regurgitation and the Trilogy TAVI valve
19 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to understand the challenges of imaging for aortic regurgitation and how it can lead to underdiagnosis. Discover the data from the ALIGN-AR trial studying TAVI in aortic regurgitation patients, and learn about the Trilogy valve and the future of TAVI...
Valve performance and durability - Main considerations in selecting the right TAVI valve
20 Nov 2023 – From PCR London Valves 2023
In this session with LIVE case, participants discuss the critical role of valve selection in influencing patient outcomes. The focus includes understanding the latest clinical outcomes of supra-annular TAVI and SAVR, exploring their practical implications. The session also highlights the contribution of novel technology Evolut FX, in...
The EVOQUE and PASCAL Precision systems in action: simulation- and case-based learning
20 Nov 2023 – From PCR London Valves 2023
This session explores the features of the PASCAL Precision and the EVOQUE tricuspid replacement systems through simulators and case presentations, while a panel of experts discuss the technology, witnessing live demonstrations of treating mitral and tricuspid regurgitation patients.
Advancements in intracoronary imaging and intervention: unmasking vulnerable plaques and optimising durable PCI outcomes
16 May 2024 – From EuroPCR 2024
Delve into this EuroPCR 2024 session to gain insights into NIRS IVUS, exploring its applications, supported by current data, and understanding its clinical significance. Learn how to utilize NIRS IVUS in PCI planning through case examples, addressing lesion characteristics such as length and calcific nodules. Explore local...
Targeting inflammation in AMI: a debate
14 May 2024 – From EuroPCR 2024
Watch this session to explore inflammation's role in AMI, from atherosclerosis to post-infarct remodeling. Find out more about IL-6's significance in future MACE risk and cardiac status deterioration post-AMI, and delve into targeting inflammation via IL-6, evaluating short and long-term impacts.
